ES535587A0 - Procedimiento de obtencion de complejos de tecnecio. - Google Patents

Procedimiento de obtencion de complejos de tecnecio.

Info

Publication number
ES535587A0
ES535587A0 ES535587A ES535587A ES535587A0 ES 535587 A0 ES535587 A0 ES 535587A0 ES 535587 A ES535587 A ES 535587A ES 535587 A ES535587 A ES 535587A ES 535587 A0 ES535587 A0 ES 535587A0
Authority
ES
Spain
Prior art keywords
oxygen
phosphorus
bonded
carbon
set forth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES535587A
Other languages
English (en)
Other versions
ES8706709A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mallinckrodt Inc
Original Assignee
Mallinckrodt Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Inc filed Critical Mallinckrodt Inc
Publication of ES535587A0 publication Critical patent/ES535587A0/es
Publication of ES8706709A1 publication Critical patent/ES8706709A1/es
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0474Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0476Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from monodendate ligands, e.g. sestamibi
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0489Phosphates or phosphonates, e.g. bone-seeking phosphonates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/141Esters of phosphorous acids
    • C07F9/142Esters of phosphorous acids with hydroxyalkyl compounds without further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/48Phosphonous acids [RP(OH)2] including [RHP(=O)(OH)]; Thiophosphonous acids including [RP(SH)2], [RHP(=S)(SH)]; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574Esters of oxyacids of phosphorus
    • C07F9/65748Esters of oxyacids of phosphorus the cyclic phosphorus atom belonging to more than one ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00Preparations for testing in vivo

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Optics & Photonics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Lubricants (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
ES535587A 1983-09-01 1984-08-31 Procedimiento de obtencion de complejos de tecnecio. Expired ES8706709A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/528,487 US4582700A (en) 1983-09-01 1983-09-01 Products and processes

Publications (2)

Publication Number Publication Date
ES535587A0 true ES535587A0 (es) 1987-06-16
ES8706709A1 ES8706709A1 (es) 1987-06-16

Family

ID=24105871

Family Applications (1)

Application Number Title Priority Date Filing Date
ES535587A Expired ES8706709A1 (es) 1983-09-01 1984-08-31 Procedimiento de obtencion de complejos de tecnecio.

Country Status (8)

Country Link
US (1) US4582700A (es)
EP (1) EP0136036B1 (es)
JP (1) JPS6072894A (es)
AT (1) ATE42898T1 (es)
AU (1) AU569751B2 (es)
CA (1) CA1220784A (es)
DE (1) DE3478086D1 (es)
ES (1) ES8706709A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE32826E (en) * 1982-08-02 1989-01-10 E. I Du Pont De Nemours And Company Cationic technetium complexes useful as radiodiagnostic agents
US4897255A (en) * 1985-01-14 1990-01-30 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
US5175343A (en) * 1985-01-14 1992-12-29 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
US4795626A (en) * 1985-05-10 1989-01-03 University Of Cincinnati 99m Tc.sup.(III) myocardial imaging agents which are non-reducable in vivo
ATE145337T1 (de) * 1988-05-02 1996-12-15 Phanos Tech Inc Verbindungen, zusammensetzungen und verfahren zum binden von bio-affektions-substanzen an oberflächenmembranen von bioteilchen
US5202109A (en) * 1988-06-10 1993-04-13 Neorx Corporation Conjugates for bone imaging and bone cancer therapy
US5089249A (en) * 1988-06-10 1992-02-18 Neorx Corporation Conjugates for bone imaging and bone cancer therapy
WO1996039622A1 (en) * 1995-06-05 1996-12-12 Mallinckrodt Medical, Inc. Method for measuring intestinal integrity
WO2021032784A1 (en) 2019-08-19 2021-02-25 Nuclear Research And Consultancy Group Platinum isotope combined with bone-targeting agents for use in anticancer drugs

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3987157A (en) * 1974-08-29 1976-10-19 Union Carbide Corporation Technetium 99-m labeled radio-diagnostic agents employing stannous tartrate and method of preparation
US4233284A (en) * 1978-03-31 1980-11-11 The Procter & Gamble Company Stabilized radiographic scanning agents
US4247534A (en) * 1978-07-31 1981-01-27 The Procter & Gamble Company Radiographic scanning agent
US4432963A (en) * 1978-07-31 1984-02-21 Mallinckrodt, Inc. Radiographic scanning agent
US4451450A (en) * 1981-10-15 1984-05-29 New England Nuclear Corporation Cationic compounds useful for making radiodiagnostic agents
US4455291A (en) * 1982-01-22 1984-06-19 New England Nuclear Corporation Accelerators for forming cationic technetium complexes useful as radiodiagnostic agents
US4374821A (en) * 1982-06-28 1983-02-22 E. R. Squibb & Sons, Inc. Myocardial imaging agent and method
US4481184A (en) * 1983-02-14 1984-11-06 E. R. Squibb & Sons, Inc. Cationic technetium (I) complexes

Also Published As

Publication number Publication date
EP0136036A3 (en) 1985-07-24
ES8706709A1 (es) 1987-06-16
AU3165284A (en) 1985-03-07
EP0136036A2 (en) 1985-04-03
JPS6072894A (ja) 1985-04-24
AU569751B2 (en) 1988-02-18
EP0136036B1 (en) 1989-05-10
US4582700A (en) 1986-04-15
JPH0424356B2 (es) 1992-04-24
DE3478086D1 (en) 1989-06-15
ATE42898T1 (de) 1989-05-15
CA1220784A (en) 1987-04-21

Similar Documents

Publication Publication Date Title
TW271395B (es)
AU1174888A (en) Ester-substituted diamenedithiols and radiolabeled complexes thereof
CA2097384A1 (en) Dithiophosphoric acid derivatives as lubricant additives
IE792242L (en) Hydroxyazole compounds
DE3160905D1 (en) Substituted imidazoles, their preparation and pharmaceutical compositions containing the same
DE3478086D1 (en) Technetium complexes and their uses
ZA86596B (en) Derivatives of imidazole,their preparation and utilisation,and pharmaceutical compositions containing these derivates
DK412686A (da) Koordinationskomplexer af substituerede isonitriler og radioaktive metaller, isaer til visualisering af vaev og knoglemarv og til maerkning af celler
IL97729A0 (en) Antiviral compositions and method for their use
EP0098140A3 (en) Myocardial imaging agent and method
IL77124A (en) 5-alkyl-1-phenyl-2-piperazinoalkylpyrazolin-3-one compoundds,their preparation and pharmaceutical compositions containing them
ES8703844A1 (es) Un procedimiento para preparar derivados de bencimidazol
IE782217L (en) 4, 9-DIHYDRO-4, 9-DIOXO-1H-NAPHTHO (2, 3-d) TRIAZOLES
EP0226259A3 (en) Cationic complex of technetium-99m
IE790108L (en) Isoquinoline compounds
DK159649C (da) 4-hydroxy-alfa-benzhydrolderivater, fremgangsmaade til fremstilling deraf, farmaceutiske praeparater indeholdende disse, samt fremgangsmaade til fremstilling af disse farmaceutiske praeparater

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970401